Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6905327 | 0.81 | KDM4E (0.32) | KDM4EGAAMAPT | |
| Hydrochloric Acid SCHEMBL6909629 | 0.78 | KDM4E (0.32) | KDM4EGAAMAPT | |
| SCHEMBL6909079 | 0.78 | GABRA1 (0.34) | KDM4EGAAMAPT | |
| SCHEMBL6909663 | 0.75 | KDM4E (0.36) | KDM4EGAAMAPT | |
| SCHEMBL6902154 | 0.71 | CA2 (0.34) | KDM4EGAAMAPT | |
| SCHEMBL6902166 | 0.71 | DRD1 (0.33) | — | |
| SCHEMBL6908459 | 0.65 | MAPT (0.36) | KDM4EGAAMAPT | |
| SCHEMBL30548758 | 0.62 | MAP2K7 (0.41) | KDM4EMAPT | |
| SCHEMBL200411 | 0.61 | MAP2K7 (0.42) | — | |
| SCHEMBL6909646 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6730626-B2 | TRANSITION METAL DERIVATIVE CAN REACT TO FORM AN IONIC COMPLEX WITH THE ALUMINOXANE | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2004-05-04 | — | — | US | disclosed |
| US-20020193536-A1 | Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production | IDEMITSU KOSAN CO. LTD. (JP) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193536-A1 | Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production | CCNE2, PYM1, AP1M1 | KDM4E 655/4885GAA 4417/4885MAPT 2296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.